Literature DB >> 21750174

The handling of missing data in molecular epidemiology studies.

Manisha Desai1, Jessica Kubo, Denise Esserman, Mary Beth Terry.   

Abstract

Molecular epidemiology studies face a missing data problem, as biospecimen or imaging data are often collected on only a proportion of subjects eligible for study. We investigated all molecular epidemiology studies published as Research Articles, Short Communications, or Null Results in Brief in Cancer Epidemiology, Biomarkers & Prevention from January 1, 2009, to March 31, 2010, to characterize the extent that missing data were present and to elucidate how the issue was addressed. Of 278 molecular epidemiology studies assessed, most (95%) had missing data on a key variable (66%) and/or used availability of data (often, but not always the biomarker data) as inclusion criterion for study entry (45%). Despite this, only 10% compared subjects included in the analysis with those excluded from the analysis and 88% with missing data conducted a complete-case analysis, a method known to yield biased and inefficient estimates when the data are not missing completely at random. Our findings provide evidence that missing data methods are underutilized in molecular epidemiology studies, which may deleteriously affect the interpretation of results. We provide practical guidelines for the analysis and interpretation of molecular epidemiology studies with missing data. ©2011 AACR.

Entities:  

Mesh:

Year:  2011        PMID: 21750174      PMCID: PMC5508724          DOI: 10.1158/1055-9965.EPI-10-1311

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  17 in total

1.  Mixed effects models with censored data with application to HIV RNA levels.

Authors:  J P Hughes
Journal:  Biometrics       Date:  1999-06       Impact factor: 2.571

2.  Longitudinal analysis of quantitative virologic measures in human immunodeficiency virus-infected subjects with > or = 400 CD4 lymphocytes: implications for applying measurements to individual patients. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group.

Authors:  W B Paxton; R W Coombs; M J McElrath; M C Keefer; J Hughes; F Sinangil; D Chernoff; L Demeter; B Williams; L Corey
Journal:  J Infect Dis       Date:  1997-02       Impact factor: 5.226

3.  Multiple imputation of discrete and continuous data by fully conditional specification.

Authors:  Stef van Buuren
Journal:  Stat Methods Med Res       Date:  2007-06       Impact factor: 3.021

Review 4.  Use of multiple imputation in the epidemiologic literature.

Authors:  Mark A Klebanoff; Stephen R Cole
Journal:  Am J Epidemiol       Date:  2008-06-30       Impact factor: 4.897

5.  Screening for HIV-associated anal cancer: correlation of HPV genotypes, p16, and E6 transcripts with anal pathology.

Authors:  Irving E Salit; Jill Tinmouth; Sylvia Chong; Janet Raboud; Christina Diong; DeSheng Su; Marie Sano; Alice Lytwyn; William Chapman; James Mahony
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-06-30       Impact factor: 4.254

6.  Parameter estimation from incomplete data in binomial regression when the missing data mechanism is nonignorable.

Authors:  J G Ibrahim; S R Lipsitz
Journal:  Biometrics       Date:  1996-09       Impact factor: 2.571

7.  Influence of high-dose estrogen exposure during adolescence on mammographic density for age in adulthood.

Authors:  Helen L Jordan; John L Hopper; Russell J Thomson; Anne M Kavanagh; Dorota M Gertig; Jennifer Stone; Alison J Venn
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-01       Impact factor: 4.254

8.  Common genetic variation in candidate genes and susceptibility to subtypes of breast cancer.

Authors:  Nasim Mavaddat; Alison M Dunning; Bruce A J Ponder; Douglas F Easton; Paul D Pharoah
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-01       Impact factor: 4.254

9.  Postmenopausal levels of endogenous sex hormones and risk of colorectal cancer.

Authors:  Tess V Clendenen; Karen L Koenig; Roy E Shore; Mortimer Levitz; Alan A Arslan; Anne Zeleniuch-Jacquotte
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-01       Impact factor: 4.254

10.  The impact of type 2 diabetes on the development of hepatocellular carcinoma in different viral hepatitis statuses.

Authors:  Chong-Shan Wang; Wei-Jen Yao; Ting-Tsung Chang; Shan-Tair Wang; Pesus Chou
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-06-23       Impact factor: 4.254

View more
  13 in total

1.  Pak1, adjuvant tamoxifen therapy, and breast cancer recurrence risk in a Danish population-based study.

Authors:  Thomas P Ahern; Deirdre P Cronin-Fenton; Timothy L Lash; Henrik Toft Sørensen; Anne Gulbech Ording; Stephen J Hamilton-Dutoit; Ylva Hellberg
Journal:  Acta Oncol       Date:  2016-04-08       Impact factor: 4.089

2.  Incomplete data: what you don't know might hurt you.

Authors:  Daniel F Heitjan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-07-12       Impact factor: 4.254

3.  MicroRNA-related polymorphisms and non-Hodgkin lymphoma susceptibility in the Multicenter AIDS Cohort Study.

Authors:  Erin C Peckham-Gregory; Dharma R Thapa; Jeremy Martinson; Priya Duggal; Sudhir Penugonda; Jay H Bream; Po-Yin Chang; Sugandha Dandekar; Shen-Chih Chang; Roger Detels; Otoniel Martínez-Maza; Zuo-Feng Zhang; Shehnaz K Hussain
Journal:  Cancer Epidemiol       Date:  2016-10-01       Impact factor: 2.984

4.  Low risk of second primary malignancies among never smokers with human papillomavirus-associated index oropharyngeal cancers.

Authors:  Brandon W Peck; Kristina R Dahlstrom; Samuel J Gan; Wes Caywood; Guojun Li; Qingyi Wei; Mark E Zafereo; Erich M Sturgis
Journal:  Head Neck       Date:  2012-06-19       Impact factor: 3.147

Review 5.  Methods for Stratification and Validation Cohorts: A Scoping Review.

Authors:  Teresa Torres Moral; Albert Sanchez-Niubo; Anna Monistrol-Mula; Chiara Gerardi; Rita Banzi; Paula Garcia; Jacques Demotes-Mainard; Josep Maria Haro
Journal:  J Pers Med       Date:  2022-04-26

6.  Accounting for EGFR Mutations in Epidemiologic Analyses of Non-Small Cell Lung Cancers: Examples Based on the International Lung Cancer Consortium Data.

Authors:  Sabine Schmid; Mei Jiang; Wei Xu; Geoffrey Liu; M Catherine Brown; Aline Fares; Miguel Garcia; Joelle Soriano; Mei Dong; Sera Thomas; Takashi Kohno; Leticia Ferro Leal; Nancy Diao; Juntao Xie; Zhichao Wang; David Zaridze; Ivana Holcatova; Jolanta Lissowska; Beata Świątkowska; Dana Mates; Milan Savic; Angela S Wenzlaff; Curtis C Harris; Neil E Caporaso; Hongxia Ma; Guillermo Fernandez-Tardon; Matthew J Barnett; Gary Goodman; Michael P A Davies; Mónica Pérez-Ríos; Fiona Taylor; Eric J Duell; Ben Schoettker; Hermann Brenner; Angeline Andrew; Angela Cox; Alberto Ruano-Ravina; John K Field; Loic Le Marchand; Ying Wang; Chu Chen; Adonina Tardon; Sanjay Shete; Matthew B Schabath; Hongbing Shen; Maria Teresa Landi; Brid M Ryan; Ann G Schwartz; Lihong Qi; Lori C Sakoda; Paul Brennan; Ping Yang; Jie Zhang; David C Christiani; Rui Manuel Reis; Kouya Shiraishi; Rayjean J Hung
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-03-01       Impact factor: 4.090

7.  Serum biomarkers of immune activation and subsequent risk of non-hodgkin B-cell lymphoma among HIV-infected women.

Authors:  Shehnaz K Hussain; Nancy A Hessol; Alexandra M Levine; Elizabeth Crabb Breen; Kathryn Anastos; Mardge Cohen; Gypsyamber D'Souza; Deborah R Gustafson; Sylvia Silver; Otoniel Martínez-Maza
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-09-17       Impact factor: 4.254

8.  Serum levels of the chemokine CXCL13, genetic variation in CXCL13 and its receptor CXCR5, and HIV-associated non-hodgkin B-cell lymphoma risk.

Authors:  Shehnaz K Hussain; Weiming Zhu; Shen-Chih Chang; Elizabeth Crabb Breen; Elena Vendrame; Larry Magpantay; Dan Widney; Daniel Conn; Mary Sehl; Lisa P Jacobson; Jay H Bream; Steven Wolinsky; Charles R Rinaldo; Richard F Ambinder; Roger Detels; Zuo-Feng Zhang; Otoniel Martínez-Maza
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-12-18       Impact factor: 4.254

9.  The use of complete-case and multiple imputation-based analyses in molecular epidemiology studies that assess interaction effects.

Authors:  Manisha Desai; Denise A Esserman; Marilie D Gammon; Mary B Terry
Journal:  Epidemiol Perspect Innov       Date:  2011-10-06

Review 10.  The reporting and handling of missing data in longitudinal studies of older adults is suboptimal: a methodological survey of geriatric journals.

Authors:  Chinenye Okpara; Chidozie Edokwe; George Ioannidis; Alexandra Papaioannou; Jonathan D Adachi; Lehana Thabane
Journal:  BMC Med Res Methodol       Date:  2022-04-26       Impact factor: 4.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.